Q3 2019
Released Nov 12, 2019, after the close
10-Q filed Nov 12, 2019, 43 days after period end · 0001493152-19-016884
Q3 2019 · 10-Q
Revenue$2.77M$2.77M +13.4% vs Q3 2018+67.5% vs Q2 2019
Net Income-$428.00K-$428.00K N/M vs Q3 2018N/M vs Q2 2019
EPS Diluted-$0.04-$0.04 N/M vs Q3 2018N/M vs Q2 2019
Gross Profit$834,000+10.3%
Operating Income-$461,000N/M
Operating Cash Flowderived-$889,000N/M
Free Cash Flowderived-$1,001,000N/M
Margins · derived
Gross margin30.2%−0.8 pt vs Q3 2018
Operating margin-16.7%+20.7 pt vs Q3 2018
Net margin-15.5%+27.9 pt vs Q3 2018
What the release said
The release
Same quarter
| Metric | Q3 2019 | Q3 2018 | Q3 2017 | Q3 2016 |
|---|---|---|---|---|
| Revenue | $2.77M | $2.44M | $3.04M | $1.40M |
| Net Income | -$428.00K | -$1.06M | -$777.00K | $167.00K |
| EPS Diluted | -$0.04 | -$0.09 | -$0.05 | $0.01 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
ProPhase Labs, Inc. · CIK 868278 · Engraved from SEC EDGAR